You are here

Company Monitoring Page for Roche

job ratings for Roche

12/28/23

industry:

company:

Roche

job rating:

1

Roche ordered Genentech to work on application of AI in drug discovery. At Roche no one really understands it, but to their surprise Genentech is not up to the task after years of dependency on Roche.The made an agreement with Invidia who will be the real beneficiary by familiarizing itself with this domain.

latest headlines for company on cafepharma

Roche CEO says no plans for job cuts, business healthy, Reuters reports

MSN/TipRanks

Fri, 01/3/25 - 11:05 am

Tags:

Roche, Thomas Schinecker

Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China

BioSpace

Thu, 01/2/25 - 11:26 am

Tags:

Roche, China, antibody-drug conjugates, small cell lung cancer

Roche reports failure of Prothena-partnered Parkinson's prospect in phase 2b but highlights positives

Fierce Biotech

Thu, 12/19/24 - 10:07 am

Tags:

Roche, Parkinson's Disease, clinical trials, Prothena Biosciences

Sanofi, Teva say study results show gut disease drug could be ‘best in class’

BioPharma Dive

Tue, 12/17/24 - 11:59 am

Tags:

Sanofi, Teva Pharmaceutical, IBD, Merck, Roche, duvakitug

3 closely watched drugs that failed in the clinic

Pharma Voice

Mon, 12/16/24 - 11:24 am

Tags:

biotech, Roche, tiragolumab, AbbVie, emraclidine, Cassava Sciences, simufilam

AbbVie to acquire Roche spinout Nimble in immune drug deal

BioPharma Dive

Fri, 12/13/24 - 11:49 am

Tags:

AbbVie, Nimble Therapeutics, M&A, IL-23, Roche

Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be

Fierce Biotech

Tue, 12/10/24 - 10:00 pm

Tags:

Roche, Poseida Therapeutics, M&A, cell therapy

Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M

BioSpace

Tue, 12/3/24 - 11:23 am

Tags:

Roche, Cour Pharmaceuticals, Genentech, autoimmune disease, immune tolerance platform

Roche to buy cell therapy developer Poseida for $1B

BioPharma Dive

Tue, 11/26/24 - 11:24 am

Tags:

Roche, Poseida Therapeutics, M&A, cell therapy, cancer

Roche records setback in phase III study of two lung cancer drugs

MSN/Reuters

Tue, 11/26/24 - 11:17 am

Tags:

Roche, anti-TIGIT, tiragolumab, Tecentriq, clnical trials, lung cancer

Roche’s tiragolumab flops in another Phase III lung cancer trial

Clinical Trials Arena

Tue, 11/26/24 - 09:53 am

Tags:

Roche, tiragolumab, clinical trials, lung cancer

Roche's Vabysmo shows potential to treat eye disorder common in Asia

Fierce Pharma

Fri, 11/22/24 - 11:19 am

Tags:

Roche, Vabysmo, age-related macular degeneration, Asia

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

Pharma Voice

Thu, 11/21/24 - 11:12 am

Tags:

Merck, Keytruda, patents, Roche, Genentech

Roche files patent suit to fend off potential Evrysdi generics from Zydus, Natco

Fierce Pharma

Wed, 11/20/24 - 11:24 am

Tags:

Roche, Evrysdi, generics, SMA, patents, Zydus, Natco

Roche teams up with transcription factor trailblazer Flare in new $1.8B-plus cancer pact

Fierce Biotech

Tue, 11/12/24 - 10:57 am

Tags:

Roche, Flare Therapeutics, cancer, small molecule drugs, drug discovery

UCB's tau drug flunks phase 2 Alzheimer's trial days after Roche's exit from $120M bet

Fierce Biotech

Fri, 11/1/24 - 10:55 am

Tags:

UCB Pharma, clinical trials, Roche, Alzheimer's disease, bepranemab

Roche’s Alzheimer’s test shows high negative predictive value

Clinical Trials Arena

Thu, 10/31/24 - 09:15 am

Tags:

Roche, diagnostics, Alzheimer's disease, Elecsys

Roche sees rapid amyloid clearing in Alzheimer's study, adjusts protocol after patient death

Fierce Biotech

Wed, 10/30/24 - 08:47 pm

Tags:

Roche, Alzheimer's disease, clinical trials, trontinemab

Backlash builds against Novo’s Catalent takeover

Pharma Voice

Wed, 10/30/24 - 11:40 am

Tags:

Novo Holdings, Novo Nordisk, Catalent, M&A, Roche

Roche Inks Potential $1B Gene Therapy Deal With Dyno, Eyes Neurological Diseases

BioSpace

Thu, 10/24/24 - 08:21 pm

Tags:

Roche, gene therapy, Dyno Therapeutics, neurological disorders

Pages

last 30 twitter posts